Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
9.19
-0.19 (-2.03%)
At close: Aug 21, 2026, 4:00 PM EDT
9.23
+0.04 (0.44%)
After-hours: Aug 21, 2026, 5:09 PM EDT
Adicet Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
102
Market Cap
98.92M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 24.99M | 15.26M | 156.83% |
| Dec 31, 2021 | 9.73M | -8.17M | -45.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ACET News
- 10 days ago - Adicet Bio Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 15 days ago - Adicet Bio price target lowered to $90 from $100 at Guggenheim - TheFly
- 16 days ago - Adicet Bio reports Q2 EPS ($1.99), consensus ($1.64) - TheFly
- 16 days ago - Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - Business Wire
- 16 days ago - Adicet Bio Quarterly report: Q2 2026 - Filings
- 16 days ago - Adicet Bio Earnings release: Q2 2026 - Filings
- 20 days ago - Adicet Bio Slides: Investor presentation - Filings
- 4 weeks ago - Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference - Business Wire